Efavize 200 Tablet contains Efavirenz 200mg, a well-established NNRTI antiretroviral agent widely used in the long-term management of HIV-1 infection. It works by inhibiting viral reverse transcriptase, thereby preventing viral replication and reducing viral load in infected individuals.
Efavirenz is commonly prescribed as part of combination antiretroviral therapy, improving immune function and helping delay disease progression. Its oral tablet formulation supports patient compliance and ease of administration under medical supervision.
For hospitals, HIV clinics, and pharmaceutical distributors, Efavize 200 Tablet is a high-demand antiretroviral medicine, routinely supplied through government programs, specialty infectious disease centers, and private healthcare institutions. Chronic therapy requirements ensure consistent procurement and repeat market movement.
Adding Efavize 200 Tablet to your product range strengthens your HIV and antiretroviral therapy segment, offering strong opportunities in hospital supply, institutional tenders, export channels, and third-party manufacturing. Its proven clinical efficacy makes it a strategically important product for pharmaceutical distributors.